Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Dactinomycin × 1 year × Clear all

Sponsor

Conditions

Rhabdomyosarcoma 4 Rhabdomyosarcoma, Embryonal 2 Wilms Tumor 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma, Alveolar 1 Pleuropulmonary blastoma 1 Hydatidiform Mole, Invasive 1 Histiocytoma, Malignant Fibrous 1 Gestational Trophoblastic Disease 1 Dermatofibrosarcoma 1 Choriocarcinoma 1 Beckwith-Wiedemann Syndrome 1

Interventions

Cisplatin 7 Etoposide 6 fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Bleomycin 3 Automobiles 3 pralsetinib 2 pembrolizumab 2 etoposide phosphate 2 Sirolimus 2 Paclitaxel 2 Mesna 2 Drug Therapy 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 tozuleristide 1 sodium thiosulfate 1 repotrectinib 1 pegfilgrastim 1 lutetium Lu 177 dotatate 1 durvalumab 1 cabozantinib 1 Vorinostat 1 Teniposide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡